NDC 63323-482-01 - Xylocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-482
- Requested NDC
- 63323-482-01
- Package NDCs from labels
- 63323-482-41, 63323-482-26, 63323-482-01, 63323-482-17, 63323-482-03, 63323-482-27, 63323-482-05, 63323-482-57
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2026-11-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xylocaine 1% (Lidocaine HCL and Epinephrine 1:100,000) USP | Henry Schein, Inc. | 2026-11-13 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-08-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - Sportpharm LLC | Sportpharm LLC | 2026-03-21 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - ProPharma Distribution | ProPharma Distribution | 2025-07-18 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
| XYLOCAINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-05-29 | HUMAN PRESCRIPTION DRUG LABEL |
| Leep RediKit | CooperSurgical, Inc. | 2023-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| LIDOCAINE HCl AND EPI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2022-07-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - Cardinal Health | Cardinal Health | 2020-06-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Cardinal Health | Cardinal Health | 2019-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
| QKit | CooperSurgical, Inc. | 2016-08-16 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine | Physicians Total Care, Inc. | 2012-02-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-482-01 | Xylocaine | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 10 | 13 | |
| 63323-482-03 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-482-05 | Xylocaine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 13 | |
| 63323-482-17 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-482-27 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-482-57 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-482-26 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-482-41 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-482 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 6 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
| 63323-482 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250515_4dd52202-8eef-4136-92dd-ada573b7cf74.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-482-01 | ML - Milliliter | 63323-482 | c7c960aa-c042-4c76-8985-abfc7ddffd35 | 1 | 2019-11-12 |
| 63323-482-03 | ML - Milliliter | 63323-482 | 683318c9-c032-429d-b0a6-5acf426a0cff | 1 | 2019-11-12 |
| 63323-482-05 | ML - Milliliter | 63323-482 | 8e4a4ff6-bc30-4291-b650-70cbca55a0ea | 1 | 2019-11-12 |
| 63323-482-10 | ML - Milliliter | 63323-482 | eeb605c4-0d24-4bcc-812b-c9af4171f021 | 1 | 2013-02-11 |
| 63323-482-17 | ML - Milliliter | 63323-482 | 174b5879-d07f-4342-8e60-68c6453f1219 | 1 | 2012-07-24 |
| 63323-482-26 | ML - Milliliter | 63323-482 | e06d4a2e-b1ab-406d-9e85-1d9d66f47f9e | 1 | 2016-06-14 |
| 63323-482-27 | ML - Milliliter | 63323-482 | 8b11b61e-7a9a-4afd-9877-cf93a6041364 | 1 | 2012-07-24 |
| 63323-482-57 | ML - Milliliter | 63323-482 | 0efa69ac-a284-4b6c-86e8-d723284f92e2 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | c901016e-9293-79dd-e053-2a95a90a0fda | 2024-01-27 | Warnings, Adverse reactions | 1737761 V13007Z41A |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e8bc96bc-7876-4906-e053-2a95a90ae6ba | 2024-01-27 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e39435a3-1f69-78c5-e053-2995a90a7fc3 | 2024-01-27 | Warnings, Adverse reactions | 1737568 V13007Z41A |
| 0.5% LIDOCAINE HCl | 0.5% LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e52fe254-8872-35ce-e053-2a95a90a339e | 2024-01-27 | Warnings, Adverse reactions | 1737343 V13007Z41A |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | e5247ed5-6170-c13f-e053-2a95a90a4101 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| XYLOCAINE- MPF (LIDOCAINE HCl ) | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e8b987c8-b5cb-74cd-e053-2a95a90a5a93 | 2024-01-27 | Warnings, Adverse reactions | NDA006488 1737761 1737762 EC2CNF7XFP |
| No More Products | GLYCERIN, KAOLIN, CALAMINE, MENTHOL | Sarati International, Inc | 102e7dbb-06dc-f4d1-e063-6394a90aa3eb | 2024-01-26 | Warnings | PDC6A3C0OX |
| Pranicura 5 | GLYCERIN, KAOLIN, CALAMINE, MENTHOL | Sarati International, Inc. | 0fe10710-ac59-4fc5-e063-6294a90a48fc | 2024-01-26 | Warnings | PDC6A3C0OX |
| Target Up and Up Pain Relieving Cleansing | BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE | TARGET CORPORATION | 0f964747-be02-c715-e063-6294a90ad91e | 2024-01-25 | Warnings | F5UM2KM3W7 V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 95351883-ec37-f94a-e053-2995a90aa36a | 2024-01-25 | Warnings, Adverse reactions | V13007Z41A |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea | 2024-01-25 | Warnings, Adverse reactions | 451W47IQ8X |
| CIRCULATION HP | ARNICA MONTANA, AURUM METALLICUM, CACTUS GRANDIFLORUS, CALCAREA CARBONICA, LACHESIS MUTUS, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, SOLIDAGO VIRGAUREA, | Energique, Inc. | 464d208b-3893-4ec6-9868-12ef6807b98d | 2024-01-23 | Warnings | 451W47IQ8X |
| DERMA SCALE HP | ARSENICUM IODATUM, BORAX, GRAPHITES, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PETROLEUM, SEPIA, SULPHUR | Energique, Inc. | 64961787-7e9a-4e6f-98ce-0f51934155cf | 2024-01-23 | Warnings | 451W47IQ8X |
| XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE) | XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | 971439ed-4507-7a30-e053-2a95a90a1f1c | 2024-01-22 | Warnings, Adverse reactions | NDA006488 1867943 30Q7KI53AK EC2CNF7XFP |
| LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE | LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 94e9f2db-af29-032e-e053-2995a90a7f7b | 2024-01-22 | Warnings, Adverse reactions | NDA006488 1868028 30Q7KI53AK EC2CNF7XFP |
| Burn First Aid | BURN FIRST AID | Dynarex Corporation | 826e08be-dffa-5a27-e053-2a91aa0a8701 | 2024-01-22 | Warnings | F5UM2KM3W7 V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 995e68a7-6986-423e-e053-2995a90acd98 | 2024-01-22 | Warnings, Adverse reactions | 1737761 1737566 V13007Z41A |
| XYLOCAINE | XYLOCAINE | HF Acquisition Co LLC, DBA HealthFirst | 0c6c5678-e987-b822-e063-6394a90ac88b | 2024-01-22 | Warnings, Adverse reactions | NDA006488 1010033 EC2CNF7XFP |
| Energy Complex | ECHINACEA (ANGUSTIFOLIA), LAPPA MAJOR, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, ADRENALINUM, ALOE, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BERBERIS AQUIFOLIUM, BERBERIS VULGARIS, BRYONIA (ALBA), CHELIDONIUM MAJUS, CROTALUS HORRIDUS, DIGITALIS PURPUREA, FERRUM METALLICUM, GLONOINUM, GLYCYRRHIZA GLABRA, HYDROCOTYLE ASIATICA, IODIUM, IRIS VERSICOLOR, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, RHUS TOX, RUTA GRAVEOLENS, THUJA OCCIDENTALIS, THYROIDINUM (BOVINE) | Health Masters LLC | 9286ca29-8190-4867-9231-b0d68180cb10 | 2024-01-22 | Warnings | 9679TC07X4 451W47IQ8X |
| Excitathyrotem | IODIUM, KALI IODATUM, HYPOTHALAMUS SUIS, HYPOPHYSIS SUIS, THYROIDINUM (SUIS), LITHIUM MURIATICUM, EPHEDRA VULGARIS | Nucleic Products, LLC | c7c705a8-d7e6-4564-aa34-39da28e0b2dd | 2024-01-22 | Warnings | 9679TC07X4 1C4QK22F9J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.